Driving New-Patient Growth and Expanding Downstream Service Opportunities with Virtual Genetic Services

Genomic medicine is transforming healthcare by making care more targeted, personalized and actionable, yet remains largely inaccessible to many patients. The growing demand for genetic services, paired with a shortage of genetic providers in many hospital settings is driving new and innovative service delivery models to bring clinical expertise where it’s needed most. Genome Medical Chief Executive Officer, Jill Davies will discuss trends in virtual genetic services and tech solutions that are enabling health systems to reach more patients, improve the patient experience and make genetic insights actionable for better care across clinical service lines.



Healthcare Innovation
Chief Executive Officer
Genome Medical


Industry Partner